Donor-derived Cell-free DNA for the Diagnosis of Kidney Transplant Rejection: An Attractive Test With Ambiguous Answers!
- PMID: 33606484
- DOI: 10.1097/TP.0000000000003696
Donor-derived Cell-free DNA for the Diagnosis of Kidney Transplant Rejection: An Attractive Test With Ambiguous Answers!
Comment on
-
Diagnostic Accuracy of Donor-derived Cell-free DNA in Renal-allograft Rejection: A Meta-analysis.Transplantation. 2021 Jun 1;105(6):1303-1310. doi: 10.1097/TP.0000000000003443. Transplantation. 2021. PMID: 32890130
References
-
- Bloom RD, Bromberg JS, Poggio ED, et al.; Circulating Donor-Derived Cell-Free DNA in Blood for Diagnosing Active Rejection in Kidney Transplant Recipients (DART) Study Investigators. Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol. 2017;28:2221–2232.
-
- Jordan SC, Bunnapradist S, Bromberg JS, et al. Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients. Transplant Direct. 2018;4:e379.
-
- Sigdel TK, Archila FA, Constantin T, et al. Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR. J Clin Med. 2018;8:19.
-
- Huang E, Sethi S, Peng A, et al. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients. Am J Transplant. 2019;19:1663–1670.
-
- Oellerich M, Shipkova M, Asendorf T, et al. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study. Am J Transplant. 2019;19:3087–3099.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
